Releaf

Releaf was launched in February 2024 as a HealthTech company dedicated to transforming access to Cannabis Based Products for Medical use (CBPMs) in the UK. Releaf are redefining the way medical cannabis supports treatment plans for an underserved segment of the UK population; offering an innovative, specialist approach to patient care and addressing issues such as a fragmented supply chain, poor patient acquisition strategies and a lack of clinical excellence. Releaf has made significant investments in developing a HealthTech platform to streamline access to CBPMs for patients with various health conditions. The platform was launched in February 2024, eliminating previous barriers and bringing about fundamental changes in the UK's CBPM sector. Our Leadership Team has a proven track record in navigating complex, regulated markets. Through substantial investments in time, money, and expertise, we have developed Releaf's HealthTech operating platform. This platform simplifies the intricate and makes the opaque transparent, ensuring a seamless, single online session for patients to access CBPMs for their relevant conditions. Press enquiries: Press@releaf.co.uk